ACI’s services have supported more than 20 product approvals in many different therapeutic areas throughout our history. Projects have been conducted for top 10 global pharmaceutical companies, major academic institutions, and several biotech, medical device and diagnostics companies.

We are proud to have partnered with such an expansive client base and to have supported the following regulatory-approved products:

Product Indication ACI Services
Budesonide/formoterol fumarate dihydrate Asthma and COPD DMC
Varenicline Smoking cessation EAC
Teduglutide Short Bowel Syndrome Data Services
Donepezil HCI Drug delivery device Alzheimer’s Data Services
Alemtuzumab Multiple Sclerosis EAC
Afatinib NSCLC DMC
Dalfampridine Multiple Sclerosis DMC
Iontophoretic Drug delivery device Pain Data Services, Stats
Tiotropium bromide inhalation powder COPD EAC, DMC
Darbepoetin alfa Breast cancer Data Services
Defibrotide Hepatic VOD Data Services
Dimethyl fumarate Multiple Sclerosis EAC
Vitespen Cancer vaccine DMC
Methylphenidate ADHD Data Services, Stats
Tetrabenazine Huntington’s disease Cardiac Safety Advisory
Dronedarone Atrial fibrillation (AFib) DMC
Linagliptin Diabetes EAC
Computer-Assisted Personalized Sedation System Anesthesiology DMC
Lurasidone HCI Schizophrenia Stats, CDISC conversion
Epoetin Alfa Anemia DMC
Mobile Cardiac Outpatient Telemetry Diagnostic Monitor Cardiac arrhythmia Advisory Services,
Data Services